OMICS Publishing Group, Biosimilars a remarkable event that is bound to set new standards in research. Biosimilars is an apt platform for scientists to collaborate and share new ideas, innovations & strategies. The scientific program paves a way to gather visionaries through the research talks and presentations and put forward many thought provoking strategies in Biowaivers & Biosimilars.

1. 2nd International Conference and
Exhibition on Biowaivers and Biosimilars
September23-25, 2013
Raleigh, North Carolina, USA

2. OCM
 Huixiao Hong
Executive Editor, National Centre for Toxicological Research,
U.S. Food and Drug Administration
 Amal Ali Elkordy
University of Sunderland, UK
 Shufeng Zhou
University of South Florida, USA
 Jagat R Kanwar
Associate Professor, Deakin University, Australia
 Aamir Shahzad
International Society for Translational Medicine (ISTM)
Austria

3. .
 Valderilio Feijó Azevedo
Federal University of Parana, Brazil
 Hu Yan
Zhengzhou University, China
 Shivanand P. Puthli
Panacea Biotec Ltd., Navi-Mumbai, India
 L.D. Patel
C.U. Shah College of Pharmacy and Research, India
 Wahajuddin
Central Drug Research Institute, India

4. Supporting Journals related to your
conference (from OMICS Group Journals)
 Journal of Bioanalysis and Biomedicine.
 Journal of Bioequivalence and Bioavailability.
 Pharmaceutical Analytica Acta

5. Related Journals (From OMICS Group Journals)
 Journal of Drug Metabolism & Toxicology.
http://www.omicsonline.org/jdmthome.php
 Journal of Drug Designing
http://www.omicsgroup.org/journals/ddohome.php

6. Related Journals (from top external publishers)
 Journal of Interchangeability, Immunogenicity and Biosimilars (Nature)
http://www.nature.com/nbt/journal/v30/n12/full/nbt.2438.html
 European Journal of Pharmaceutics and Biopharmaceutics (Science Direct)
http://www.sciencedirect.com/science/article/pii/S0939641109000770
 Journals of Biosimilars (Dove press)
http://www.dovepress.com/call-for-papers-biosimilars-d228-j113
 Journal of Biosimilars & Biowaivers (SciTechnol)
http://www.scitechnol.com/jbsbwhome.php
 GENERICS AND BIOSIMILARS INITIATIVE JOURNAL
http://gabi-journal.net/

7. Top Biosimilar (Research Lab)
Research Lab Research
Novartis (Sandoz) Focus on expanding biosimilars product
portfolio
Bioton Expansion of biosimilars portfolio in drug
categories other than insulin
Teva Investing in R&D and manufacturing
capabilities
LG Life Sciences Targeting the antibody treatment
segment
Biocon the insulin production

8. Societies/ Associations/ Organization/ Institutes
 Generic Pharmaceutical Association
 European Generic medicines Association
 BIO-Biotechnology industry Organization
 Biosimilar Medicines-international Alliance of
patients organization